Allarity Therapeutics (ALLR) Exchange Rate Effect (2020 - 2026)
Allarity Therapeutics' (ALLR) quarterly Exchange Rate Effect came in at -$58000.0 in Q1 2026, up 79.72% YoY from -$32272.4 in Q1 2025, and down 104.52% on a QoQ basis from $1.3 million in Q4 2025.
Allarity Therapeutics (ALLR) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Allarity Therapeutics (ALLR) has 7 years of Exchange Rate Effect data on file, last reported at -$58000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 79.72% year-over-year to -$58000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$439000.0 (down 94.25% YoY) and the FY2025 annual result came in at -$667000.0, down 396.44% from the prior year.
- Exchange Rate Effect retreated to -$58000.0 in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.3 million in Q4 2025 to a low of -$1.9 million in Q2 2025.
- A 5-year average of -$47176.5 and a median of -$83000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2023 — Exchange Rate Effect jumped 575.38% — and 2025, when it slumped 2110.71%.
- Tracing ALLR's Exchange Rate Effect over 5 years: stood at -$453000.0 in 2022, then jumped by 81.68% to -$83000.0 in 2023, then jumped by 508.43% to $339000.0 in 2024, then surged by 278.17% to $1.3 million in 2025, then slumped by 104.52% to -$58000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$58000.0 (Q1 2026), $1.3 million (Q4 2025), and $194000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | - |
| 10 | Allarity Therapeutics | 22.75 Mn | 22.75 Mn | - | -267,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -58,000.00 |
| Mar 31, 2026 | -58,000.00 |
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 194,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.86 Mn |
| Mar 31, 2025 | -286,000.00 |
| Mar 31, 2025 | -286,000.00 |
| Dec 31, 2024 | 339,000.00 |
| Dec 31, 2024 | 339,000.00 |
| Sep 30, 2024 | -195,000.00 |
| Sep 30, 2024 | -195,000.00 |
| Jun 30, 2024 | -84,000.00 |
| Jun 30, 2024 | -84,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | -83,000.00 |
| Dec 31, 2023 | -83,000.00 |